• Molecular NamePentagastrin
  • SynonymNA
  • Weight767.905
  • Drugbank_IDDB00183
  • ACS_NO5534-95-2
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)2.25
  • pkaN/A
  • LogD (pH=7, predicted)-0.84
  • Solubility (experiment)Insoluble
  • LogS (predicted, ACD/Labs)(ph=7)-2.33
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.02
  • No.of HBond Donors9
  • No.of HBond Acceptors16
  • No.of Rotatable Bonds23
  • TPSA276.21
  • StatusFDA approved
  • AdministrationParenteral administration.
  • PharmacologyUsed as a diagnostic aid as the pentagastrin-stimulated calcitonin test.
  • Absorption_valueN/A
  • Absorption (description)Rapidly absorbed after parenteral administration.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life10 min or less
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A